Home
About
FAQ
History (16)
Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide.
Psychogenic movement disorders.
Dementia: the leading predictor of death in a defined elderly population: the Cache County Study.
D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care.
Botulinum toxin for the treatment of movement disorders.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Botulinum toxin for the treatment of movement disorders.
Thenganatt MA, Fahn S. Botulinum toxin for the treatment of movement disorders. Curr Neurol Neurosci Rep. 2012 Aug; 12(4):399-409.
View in:
PubMed
subject areas
Animals
Blepharospasm
Botulinum Toxins
Hemifacial Spasm
Humans
Movement Disorders
Treatment Outcome
authors with profiles
Mary Ann Thenganatt MD